Novalab Critical Care

Novalab Critical Care is a specialized division of Novalab Healthcare Private Limited (NHPL) based in Panchkula, Haryana, established in 2014. It operates as a critical care PCD pharma franchise company offering hospital-focused injectables and IV infusions, including carbapenems, reserve antibiotics, inotropes, steroids, iron therapy, and amino acid infusions. The business provides monopoly rights for distributors and entrepreneurs seeking organized product supply and marketing support across India.

The company offers exclusive monopoly rights for partners within their specific district or territory, ensuring they are the sole distributors for the critical care range in that area. This model is designed for pharma professionals, distributors, and entrepreneurs who want to build a business around high-demand hospital-focused products with steady supply from the Panchkula headquarters.

Partners gain access to a portfolio of over 150 critical care formulations, which includes neuro care, gastro care, pain management solutions, and specialty formulations. The company handles product range, quality documents, packaging, promotional inputs, and dispatch directly from their Panchkula facility to ensure hospital-ready standards.

The manufacturing facilities are WHO-GMP certified and the company holds ISO 9001:2015 certification for its quality management systems. All products comply with applicable Indian regulatory standards and are manufactured under DCGI-approved molecules to ensure consistency and safety for hospital pharmacies.

The company was founded in 2014 and has been serving the pharmaceutical sector since then, with a dedicated division launched in 2024 to focus specifically on critical care pharmaceutical products. This long-standing presence in the industry supports their claim of being India's most trusted critical care PCD pharma company.

Partners can start by downloading the product list or filling out the franchise enquiry form on the website to connect with the business development team. The process involves selecting a territory, signing up for monopoly rights, and receiving promotional inputs and timely product availability from the Panchkula dispatch center.

The company offers third-party critical care manufacturing services for brands that need consistency, scalability, and professional pharma production. This service includes WHO-GMP quality standards, custom product manufacturing, bulk production support, and quality packaging solutions for external clients.

The product portfolio covers a wide range of critical care injectables, antibiotics, and specialty formulations designed specifically for hospital buying patterns rather than retail chemist counters. These products are essential for ICU and emergency wards where orders are frequently placed by molecule.

The company explicitly mentions that they take care of promotional inputs and dispatch from Panchkula, ensuring that batch documents and proper labelling meet hospital pharmacy requirements without back-and-forth. This logistical support is a key feature for partners managing hospital relationships.

The business model is described as a hospital-focused critical care range with monopoly rights across India, targeting those who need a dedicated portfolio backed by a trusted company. It is suitable for anyone looking for organized product supply and marketing support in the growing Indian healthcare market.

The company highlights that their critical care range covers high-demand molecules like inotropes and steroids, which are crucial for emergency and ICU settings. This specific focus on hospital-grade injectables distinguishes their offering from general retail pharma products.

Novalab Critical Care is located at Plot No-208, Industrial Area Phase 1, Panchkula,.

You can reach Novalab Critical Care by phone at 9371300000.

The official website of Novalab Critical Care is novalabcriticalcare.com.